South Asian Journal of Cancer最新文献

{"title":"Cervical Cancer in Bangladesh.","authors":"A F M Kamal Uddin, Mostafa Aziz Sumon, Shahana Pervin, Farzana Sharmin","doi":"10.1055/s-0043-1764202","DOIUrl":"https://doi.org/10.1055/s-0043-1764202","url":null,"abstract":"Bangladesh is a densely populated country having a population of 165,158,616asper the census2022.Among them83,347,206 are female and here majority of them (113,063,587) lives in rural area.1 The allocation of health sector budget is 2.34% of gross domestic product and in the year 2018, share of 75.3% of the total health expenditure was from private sector with an annual growth of 0.93%.2 There is no national cancer registry of the country. As per GOLOBOCAN 2020, the age-standardized incidence rate ofcancer ofBangladesh is calculated as 106.2 and the case load of cancer in Bangladesh was 1,56,775 and the cancer death was 1,08,990.3 Cervical cancer is the fourth most common cancer globally among women. In the year 2020, an estimated 6,04,000 new cases and 3,42,000 deaths were recorded. Alarmingly 90% of these new case and deaths occurred worldwide in 2020 were in lowand middle-income countries. The annual number of global new cases of cervical cancer has been projected to increase between 2018 and 2030 from 570,000 to 700,000 and the annual number of deaths projected to increase from 311,000 to 400,000.4 In Bangladesh, cervical cancer is the secondmost common cancer of female (12%).3 The number of new cases was 8,068 (10.6 per 100,000 women) and deaths was 5.214 (7.1 per 100,00 women) in 2018.3 The prediction was that without any intervention a total of 505,703 women in Bangladesh will die from cervical cancer by the year 2070 and the number will rise to 1,042,859 by 2120.5 The Government of Bangladesh (GOB) is giving due emphasis to noncommunicable disease (NCD) to achieve the target of sustainable development goalwhere cervical cancer management is considered as an important component of NCD. Both the government and private sectors are working together to fight against cervical cancer.","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"36-38"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/40/a6/10-1055-s-0043-1764202.PMC9966158.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cervical Cancer Screening and HPV Vaccination in Nepal.","authors":"Gehanath Baral","doi":"10.1055/s-0043-1764155","DOIUrl":"https://doi.org/10.1055/s-0043-1764155","url":null,"abstract":"Cervical cancer screening is still an opportunistic mode of procedure. Conventional pap smear was the first method used for long, then the visual method introduced in practice. However, it has been limited to the mid-level paramedics with lesser priority in facility level. Specialist service providers put more effort on newer methods like liquid-based cytology and human papillomavirus (HPV) DNA testing but without feasible and affordable system in place. Cervical cancer prevention and control program is in place from the Department of Health Services but still the implementation part is poor. Systematic approach is being followed if the screening is a part of research or thesis from academia. Screening and treatment of invasive lesions are not linked yet in practice because of poor implementation of public– private partnership considering a huge magnitude of service from private sector.","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"53-54"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/60/74/10-1055-s-0043-1764155.PMC9966170.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9138067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HPV Vaccination as a Mode of Cervical Cancer Prevention in Pakistan.","authors":"Asma Burney, Ramsha Zafar","doi":"10.1055/s-0043-1764211","DOIUrl":"https://doi.org/10.1055/s-0043-1764211","url":null,"abstract":"In Pakistan, cervical cancer continues to be a challenge. About 68.6millionwomen over the age of 15 are at risk of developing cervical cancer, with the annual number of cases being over 5,000. Of these, more than 3,000 women lose their lives, making cervical cancer the third leading cause of cancerrelated deaths in women of the reproductive age group in Pakistan. In the country, 88% of cervical cancer cases are due to humanpapillomavirus (HPV) serotypes 16 and 18, as reported by the International Agency for Research on Cancer.1 HPV is a nonenveloped DNA virus belonging to the Papillomaviridae family, with over a hundred different serotypes. Of which, 15 to 20 are oncogenic, with 16 and 18 being the most common. HPV is transmitted via sexual activity. It is found that 75% of all sexually active adults are estimated to be positive for at least one HPV serotype. However, most of these infections have spontaneous resolution with only less than 1% progressing to cancer.2 This progression can be reduced by regular screening via pap smears. The developed world has seen a significant decline in cervical cancer mortality since screening through pap smears introduced to the population. Unfortunately, in developing countries like Pakistan, the uptake of pap smears is very limited, estimated at one instance to be as low as 2%.3 In such circumstances, where pap smears are already difficult to conduct and have low uptake, HPV vaccinations become even more crucial for cervical cancer prevention. Two globally licensed HPV vaccines have been introduced in Pakistan: a quadrivalent vaccine Gardasil (marketed by Merck, Pakistan) and a bivalent vaccine Cervarix (marketed by GlaxoSmithKline, Pakistan). Gardasil is protective against the HPV serotypes 6, 11, 16, and 18, providing protection against both cervical cancer and genital warts. On the other hand, Cervarix is effective against serotypes 16 and 18, thereby protecting only against cervical cancer. It is important to note that both these vaccines work prophylactically and do not have any effect on pre-existing infections.2 Despite their introduction in Pakistan, there is a dearth of awareness regarding these vaccines and a low uptake in the general population. One study done in women of the reproductive age group at a tertiary care center in Karachi estimated the awareness of HPV vaccines to be as low as 20% and their uptake to be less than 10%.4","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"51-52"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/07/78/10-1055-s-0043-1764211.PMC9966174.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role of Circulating Tumor Cells in Determining Prognosis in Metastatic Breast Cancer.","authors":"Sonia Dhaka,&nbsp;Rupal Tripathi,&nbsp;Dinesh Chandra Doval,&nbsp;Anurag Mehta,&nbsp;Udip Maheshwari,&nbsp;Venkata Pradeep Babu Koyyala,&nbsp;Jatinderpal Singh","doi":"10.1055/s-0042-1753477","DOIUrl":"https://doi.org/10.1055/s-0042-1753477","url":null,"abstract":"<p><p>Dinesh Chandra Doval<b>Background</b>  Circulating tumor cells (CTCs) in the peripheral blood may play a major role in the metastatic spread of breast cancer. This study was conducted to assess the role of CTCs to determine the prognosis in terms of survival in metastatic breast cancer patients. <b>Methods</b>  This prospective study of 36 patients was conducted at the Hospital from April 2016 to May 2018. Details of each patient related to the demographic profile, tumor type, treatment, and follow-up information were recorded. The number of CTCs in the peripheral blood was measured by Celsee PREP 400 sample processing system and Celsee Analyzer imaging station. <b>Results</b>  There was a positive correlation between the number of site of metastasis with number of CTCs ( <i>p</i> -value < 0.001). In the patients with clinical/partial response, a significant reduction in the number of CTCs after 1 month of therapy was observed ( <i>p</i> -value = 0.003). When the number of CTCs at baseline and 6 months were compared with the positron emission tomography response at 6 months, a statistically significant difference in CTCs in patients having partial response after 6 months was observed ( <i>p</i> -value = 0.001). On comparison with the responder groups, a statistically significant reduction in CTCs at baseline and 6 months was observed ( <i>p</i> -value = 0.001). Patients with CTCs less than 5 and more than or equal to 5 after 1 month of treatment had a mean progression-free survival of 11.1 months and 7.5 months ( <i>p</i> -value = 0.04) and a mean overall survival of 11.6 and 9.6 months ( <i>p</i> -value = 0.08), respectively. <b>Conclusion</b>  Assessment of CTCs provides a more quantifiable response than radiographic evaluation and at a much earlier time point and is also a better predictor of survival.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"62-67"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7b/23/10-1055-s-0042-1753477.PMC9966169.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence, Characteristics, and Correlates of Fatigue in Indian Breast Cancer Survivors: A Cross-Sectional Study.","authors":"Navneet Kaur,&nbsp;Puneet Prasan Mahapatra,&nbsp;Sagar Chakraborty","doi":"10.1055/s-0042-1749319","DOIUrl":"https://doi.org/10.1055/s-0042-1749319","url":null,"abstract":"<p><p>Navneet Kaur<b>Background</b>  Fatigue is one of the commonest sequelae of breast cancer treatment that adversely impacts quality of life (QOL) of breast cancer survivors (BCSs). However, very limited data are available about cancer-related fatigue in Indian patients. Hence, this study was planned with the objectives to study (1) prevalence of fatigue in short-, intermediate-, and long-term follow-up; (2) severity and characteristics of fatigue; (3) impact of fatigue on QOL; and (4) correlation of fatigue with other survivorship issues. <b>Materials and Methods</b>  The study was conducted on ( <i>n</i>  = 230) BCSs who had completed their primary treatment (surgery, radiotherapy, and chemotherapy) and were coming for follow-up. The prevalence of fatigue was noted from a screening tool, which comprised of 14 commonly reported survivorship issues. Assessment of fatigue was done by using survivorship fatigue assessment tool-1 score and QOL was assessed by functional assessment of cancer therapy-breast (FACT-B) questionnaires. To understand how fatigue evolved over time, survivors were divided into three groups according to the time elapsed since initial treatment: Group 1: <2 years ( <i>n</i>  = 105); Group 2: 2-5 years ( <i>n</i>  = 70); Group 3: >5 years ( <i>n</i>  = 55). <b>Statistical Analysis</b>  Data was analyzed by using simple descriptive statistics, one way analysis of variance followed by Tukey's test for comparison of quantitative data among the three groups, and Pearson correlation coefficients for association of fatigue with other survivorship issues. <b>Results</b>  Clinically significant fatigue (≥4) was noted in 38% of BCSs. However, high overall prevalence of fatigue (60%) was seen, which persisted in long-term survivors (51%) as well. Severity of fatigue was mostly mild (37.7%) to moderate (47.1%). Fatigue scores were significantly higher in short-term survivors <b>(</b> 5.01 ± 2.06) than intermediate- (4.03 ± 1.42) and long-term BCSs (3.57 ± 1.37). The mean score on FACT-B was 90.07 ± 10.17 in survivors with fatigue and 104.73 ± 7.13 in those without fatigue ( <i>p</i>  = 0.000). Significant correlation of fatigue was seen with other survivorship issues like limb swelling, chronic pain, premature menopause, and its related symptoms and emotional distress. <b>Conclusion</b>  Fatigue is highly prevalent in BCSs. Survivorship care programs should include appropriate measures to evaluate and address fatigue.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"55-61"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/c1/10-1055-s-0042-1749319.PMC9966180.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10805961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"NIPEC with Single-Dose Intraperitoneal Cisplatin and Paclitaxel in Stage III Epithelial Ovarian Cancer.","authors":"Elroy Saldanha,&nbsp;Sanjay M Desai,&nbsp;Dhruv G Patel,&nbsp;Vinod Dhakad,&nbsp;Bonny Joseph,&nbsp;Sandeep Ghosh,&nbsp;Varun Prakash,&nbsp;Harsha Deepti,&nbsp;Ashma Monteiro","doi":"10.1055/s-0042-1751098","DOIUrl":"https://doi.org/10.1055/s-0042-1751098","url":null,"abstract":"<p><p>Sanjay M. Desai<b>Objectives</b>  Epithelial ovarian cancer (EOC) is a heterogeneous, essentially peritoneal disease. Standard treatment consists of staging, cytoreductive surgery (CRS), and adjuvant chemotherapy. In this study, we intended to assess the effectiveness of single-dose intraperitoneal (IP) chemotherapy in optimally debulked advanced EOC patients. <b>Materials and Methods</b>  A prospective randomized study of 87 patients with advanced EOC was done from January 2017 to May 2021 in a tertiary care center. Patients who underwent primary and interval cytoreduction received a single dose of IP chemotherapy for 24 hours after being divided into four groups: group A, IP cisplatin; group B, IP paclitaxel; group C, IP paclitaxel and cisplatin; and group D, saline. Pre- and postperitoneal IP cytology was assessed along with possible complications. <b>Statistical Analysis</b>  Logistic regression analysis was used to assess for intergroup significance in cytology and complications. Kaplan-Meir analysis was done to assess disease-free survival (DFS). <b>Results</b>  Of 87 patients, 17.2% of patients had FIGO stage IIIA, 47.2% had IIIB, and 35.6% had IIIC. Also, 22 (25.3%) patients were in group A (cisplatin), 22 (25.3%) patients in group B (paclitaxel), 23 (26.4%) in group C (cisplatin and paclitaxel), and 20 (23%) in group D (saline). Cytology samples taken during staging laparotomy were positive, and 48 hours post-IP chemotherapy, 2 (9%) of 22 samples in cisplatin group and 14 (70%) of 20 samples in saline group were positive; all of the post-IP samples in groups B and C were negative. No major morbidity was noted. In our study, DFS in saline group was 15 months, while in IP chemotherapy group it was 28 months and was statistically significant based log-rank test. However, there was no significant difference in DFS between different IP chemotherapy groups. <b>Conclusion</b>  Complete or optimal CRS in advanced EOC does have a possibility of microscopic peritoneal residue. Adjuvant locoregional strategies should be considered to prolong DFS. Single-dose normothermic IP chemotherapy can be offered to the patients with minimal morbidity, and its prognostic benefits are comparable to hyperthermic IP chemotherapy. Future clinical trials are required to validate these protocols.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"74-80"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/95/c9/10-1055-s-0042-1751098.PMC9970754.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9368931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal.","authors":"Gehanath Baral,&nbsp;Rajendra Baral","doi":"10.1055/s-0043-1764405","DOIUrl":"https://doi.org/10.1055/s-0043-1764405","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1055/s-0043-1764155.].</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"e1"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cc/80/10-1055-s-0043-1764405.PMC10017259.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9146321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"MRI Features of Synchronous Masses in Known Breast Cancer Patients in Predicting Benign Versus Malignant Lesions: A Case Based Review at Tertiary Care Cancer Hospital.","authors":"Sara Rehman,&nbsp;Bushra Rehman,&nbsp;Anis Ur Rehman,&nbsp;Islah Ud Din,&nbsp;Aamer Iftikhar,&nbsp;Ainy Javaid,&nbsp;Muhammad Asad Parvaiz","doi":"10.1055/s-0042-1755468","DOIUrl":"https://doi.org/10.1055/s-0042-1755468","url":null,"abstract":"<p><p>Sara Rehman<b>Objectives</b>  The purpose of this study was to determine the diagnostic accuracy of breast magnetic resonance imaging (MRI) in classifying incidental satellite masses in biopsy-proven breast cancer patients as benign or malignant masses and assessing its impact on surgical management of these patients. We also analyzed the incidence of MRI-detected lesions, which were thereafter assessed with second look ultrasound (US). <b>Materials and Methods</b>  A retrospective study was performed on breast cancer patients presenting from August 01, 2016 to July 31, 2019, with satellite masses seen on base line MRI. Satellite masses were classified as benign and malignant based on MRI features of shape, margin, T2-weighted imaging signals, internal enhancement pattern, enhancement kinetic curves, and diffusion restriction. This was compared with results of histopathological examination. The number of MRI-detected lesions, location of the satellite mass, and type of surgery were also documented. <b>Results</b>  Out of 400 breast cancer patients undergoing MRI breast, 115 patients had multiple masses. Histopathological diagnosis was available for 73 patients; and a total of 93 satellite masses were evaluated. There was evidence of additional masses on second look ultrasound in 21 patients. Of 72 masses classified as malignant on MRI, 58 showed malignant pathological outcome; while out of 21 masses characterized as benign on MRI, 18 turned out to be benign on histopathology. A statistically significant association was found between MRI features and pathological outcome of satellite masses ( <i>p</i>  = 0.001). The sensitivity, specificity, positive and negative predictive values, and accuracy were 95%, 56%, 80.56%, 85.7% and 81.7%, respectively. Based on these findings, modified radical mastectomy (MRM)/mastectomy was done for 42 patients, 5 patients underwent lumpectomy limited to a single tumor, extended resection done for 14 patients, 5 underwent bilateral breast conservation surgery (BCS), BCS for contralateral breast done for 4 patients undergoing ipsilateral MRM/mastectomy, and bilateral MRM/mastectomies were performed for 2 patients. One patient was lost to follow up. <b>Conclusion</b>  Breast MRI is the most sensitive modality for the assessment of breast cancer and plays an essential role in the detection of additional tumor foci. These findings can modify the surgical approach in these patients. However, considering the low specificity, biopsy of satellite masses is imperative to determine the most appropriate surgical plan.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"68-73"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/00/d9/10-1055-s-0042-1755468.PMC9966179.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge and Attitude of Cervical Cancer Screening and Vaccination in Patients Attending Gynecology Outpatient Clinic at a Tertiary Care Hospital in Pakistan.","authors":"Shamaila Shamaun,&nbsp;Riffat Jaleel,&nbsp;Yasmeen Gull,&nbsp;Afshan Shahid,&nbsp;Mehreen Iqbal,&nbsp;Tabinda Naseer Qazi","doi":"10.1055/s-0042-1751093","DOIUrl":"https://doi.org/10.1055/s-0042-1751093","url":null,"abstract":"<p><p>Shamaila Shamaun<b>Background</b>  Cervical cancer is the third most prevalent female cancer in Pakistan; nearly 70% present at a very advanced stage of malignancy due to lack of awareness, proper screening, and vaccination. Therefore, we aimed to assess the knowledge and attitude toward screening, vaccination, and risk factors of cervical cancer in sexually active women of Pakistan. <b>Methods</b>  This cross-sectional study was conducted at the gynecology outpatient clinic of a public sector hospital in Karachi, Pakistan, from December 2021 to March 2022. We included sexually active women with exception of diagnosed cases of cervical cancer, pregnancy, vaginal bleeding, and psychological disorder. Collected data were regarding demographic characteristics, awareness regarding cervical cancer, screening, human papillomavirus (HPV) vaccine, and risk factors, history of cervical screening, and wiliness to opt-in for cervical screening. <b>Results</b>  We included 226 women with a mean age of 41.25 ± 10.54 years. The mean parity level was observed to be 3.8 ± 1.95. A majority of women were housewives by profession (88.9%) and uneducated (61.9%). Only 41.2% (93) of women were aware of cervical cancer, 33.6% (76) were aware of cervical screening, and only 15.9% (36) had a history of cervical screening. Only four women (1.8%) were aware of the HPV vaccine and 31% (70) showed intention to opt-in for cervical screening. A vast majority of women (96.9%) were not aware of the risk factors of cervical cancer. <b>Conclusion(s)</b>  We have observed poor awareness regarding cervical cancer, HPV vaccination, and cervical screening among women in our population. Lack of awareness was not restricted to a certain segment but it prevails all across the demographic in our population.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"17-22"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/0e/10-1055-s-0042-1751093.PMC9966166.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Relationship between Gynecological Cancer Awareness and Self-Care Agency in Married Women.","authors":"Nursel Alp Dal,&nbsp;K Derya Beydağ,&nbsp;Özlem Ikde Öner","doi":"10.1055/s-0042-1754344","DOIUrl":"https://doi.org/10.1055/s-0042-1754344","url":null,"abstract":"<p><p>Nursel Alp Dal<b>Objective</b>  This study was conducted to determine the relationship between gynecological cancer awareness and self-care agency among married women. <b>Materials and Methods</b>  This descriptive and cross-sectional study was performed with 819 women who presented to the obstetrics polyclinic of a hospital located in the west of Turkey between December 15, 2020 and April 15, 2021. The data of the study were collected by using the Exercise of Self-Care Agency Scale (ESCA) and the Gynecological Cancers Awareness Scale (GCAS). <b>Results</b>  The mean age of the participants was 37.62 ± 9.181 years. The mean ESCA score of the women who participated in this study was 95.89 ± 25.060, which indicated moderate levels of self-care agency. The mean total GCAS score of the participants of this study was 156.57 ± 32.930, which indicated high levels of gynecological cancer awareness among the women. As the self-care agency of the women increased, their awareness of gynecological cancers also increased. <b>Conclusion</b>  Midwives and nurses who provide preventive and supportive healthcare services may affect the self-care agency of women positively by gynecological cancer awareness they will raise in these women.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"12 1","pages":"30-35"},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fc/7a/10-1055-s-0042-1754344.PMC9966168.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10813469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}